BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 25815776)

  • 21. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.
    Chen JT; Yao KH; Hua L; Zhang LP; Wang CY; Zhang JJ
    Int J Clin Exp Pathol; 2015; 8(9):10922-8. PubMed ID: 26617808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.
    Lu R; Ji Z; Li X; Qin J; Cui G; Chen J; Zhai Q; Zhao C; Zhang W; Yu Z
    Tumour Biol; 2015 Sep; 36(9):6691-700. PubMed ID: 25813153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
    Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
    Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-381-3p Confers Protection Against Ischemic Stroke Through Promoting Angiogenesis and Inhibiting Inflammation by Suppressing Cebpb and Map3k8.
    Li J; Lv H; Che Y
    Cell Mol Neurobiol; 2020 Nov; 40(8):1307-1319. PubMed ID: 32297103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
    He H; Liao X; Yang Q; Liu Y; Peng Y; Zhong H; Yang J; Zhang H; Yu Z; Zuo Y; Guan C; Xu Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818809993. PubMed ID: 30381030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-411 functions as a tumor suppressor in renal cell cancer.
    Zhang X; Zhang M; Cheng J; Lv Z; Wang F; Cai Z
    Int J Biol Markers; 2017 Oct; 32(4):e454-e460. PubMed ID: 28708205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
    Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
    J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.
    Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Mao X; Chen Y; Lai Y
    Oncol Rep; 2016 Apr; 35(4):1967-78. PubMed ID: 26796749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2.
    Dong Y; Gao Y; Xie T; Liu H; Zhan X; Xu Y
    Biomed Res Int; 2021; 2021():9950749. PubMed ID: 34307682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
    Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z
    J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.